Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. - McGuire JJ; Frieling JS; Lo CH; Li T; Muhammad A; Lawrence HR; Lawrence NJ; Cook LM; Lynch CC (Nature communications, 2021)